Todd C Brady Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd C Brady.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd C Brady. Todd C Brady is President and CEO in Aldeyra Therapeutics, Inc. ($ALDX) and Director in Evoke Pharma Inc ($EVOK) and Director in Spring Bank Pharmaceuticals, Inc. ($SBPH) and in Oncobiologics, Inc. ($ONS) and Director in Oncobiologics, Inc. ($ONS).
Latest Insider Trading Transactions of Todd C Brady
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDX, EVOK, SBPH, OTLKW
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2021 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 11.71 | 250,000 | 2,927,500 | 250,000 | |
| Apr 14 2021 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 46,619 | 0 | 948,835 | 902.2 K to 948.8 K (+5.17 %) |
| Oct 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 9,235 | 0 | 60,016 | 50.8 K to 60 K (+18.19 %) |
| Jul 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 8,418 | 0 | 50,781 | 42.4 K to 50.8 K (+19.87 %) |
| Jun 25 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 1.60 | 7,500 | 12,000 | 7,500 | |
| May 29 2020 | EVOK | Evoke Pharma Inc | Brady Todd C | Director | Option Exercise | A | 2.60 | 57,750 | 150,150 | 57,750 | |
| Apr 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 13,306 | 0 | 42,363 | 29.1 K to 42.4 K (+45.79 %) |
| Mar 04 2020 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 3.78 | 450,865 | 1,704,270 | 450,865 | |
| Mar 04 2020 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 3.78 | 250,000 | 945,000 | 250,000 | |
| Mar 04 2020 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 902,216 | 652.2 K to 902.2 K (+38.33 %) |
| Jan 02 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 7,832 | 0 | 29,057 | 21.2 K to 29.1 K (+36.90 %) |
| Dec 18 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.10 | 20,000 | 101,908 | 652,216 | 632.2 K to 652.2 K (+3.16 %) |
| Oct 02 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.68 | 8,710 | 49,483 | 632,216 | 623.5 K to 632.2 K (+1.40 %) |
| Oct 01 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 3,597 | 0 | 21,225 | 17.6 K to 21.2 K (+20.41 %) |
| Oct 01 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 3,597 | 0 | 21,225 | 17.6 K to 21.2 K (+20.41 %) |
| Sep 25 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.81 | 8,680 | 50,433 | 623,506 | 614.8 K to 623.5 K (+1.41 %) |
| Sep 20 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.91 | 14,288 | 84,465 | 614,826 | 600.5 K to 614.8 K (+2.38 %) |
| Sep 17 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 6.03 | 3,000 | 18,090 | 591,991 | 589 K to 592 K (+0.51 %) |
| Sep 17 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.79 | 10,000 | 57,900 | 588,991 | 579 K to 589 K (+1.73 %) |
| Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.39 | 10,000 | 53,937 | 578,991 | 569 K to 579 K (+1.76 %) |
| Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 4.89 | 10,000 | 48,887 | 568,991 | 559 K to 569 K (+1.79 %) |
| Jul 11 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 4.62 | 7,500 | 34,650 | 7,500 | |
| Jul 01 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 3,354 | 0 | 17,628 | 14.3 K to 17.6 K (+23.50 %) |
| May 03 2019 | EVOK | Evoke Pharma Inc | Brady Todd C | Director | Option Exercise | A | 0.72 | 34,000 | 24,480 | 34,000 | |
| Mar 07 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 8.05 | 45,329 | 364,898 | 45,329 | |
| Mar 07 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 8.05 | 250,000 | 2,012,500 | 250,000 | |
| Mar 07 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 556,054 | 306.1 K to 556.1 K (+81.68 %) |
| Jun 19 2018 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 13.99 | 5,500 | 76,945 | 5,500 | |
| Mar 08 2018 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 8.60 | 217,293 | 1,868,720 | 217,293 | |
| Mar 08 2018 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 101,269 | 0 | 302,483 | 201.2 K to 302.5 K (+50.33 %) |
| Oct 30 2017 | ONS | Oncobiologics, Inc ... | Brady Todd C | Director | Option Exercise | A | 1.32 | 15,000 | 19,800 | 15,000 | |
| Jun 16 2017 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 14.27 | 5,500 | 78,485 | 5,500 | |
| May 05 2017 | EVOK | Evoke Pharma Inc | Brady Todd C | Director | Option Exercise | A | 2.72 | 34,000 | 92,480 | 34,000 | |
| Mar 07 2017 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 5.10 | 250,000 | 1,275,000 | 250,000 | |
| Mar 07 2017 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 136,806 | 0 | 201,214 | 64.4 K to 201.2 K (+212.41 %) |
| Feb 21 2017 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 4.50 | 22,223 | 100,004 | 64,408 | 42.2 K to 64.4 K (+52.68 %) |
| Nov 23 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 10.79 | 10,964 | 118,302 | 10,964 | |
| Nov 23 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 9.12 | 10,964 | 99,992 | 10,964 | 0 to 11 K |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Buy | M | 0.00 | 28,985 | 0 | 153,288 | 124.3 K to 153.3 K (+23.32 %) | |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Sell | C | 0.00 | 28,985 | 0 | 28,985 | 58 K to 29 K (-50.00 %) | |
| Jul 29 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 9.05 | 11,000 | 99,550 | 11,000 | |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Director | Option Exercise | C | 0.00 | 398 | 0 | 0 | |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Director | Buy | C | 0.00 | 66,333 | 0 | 124,303 | 58 K to 124.3 K (+114.43 %) |
| May 05 2016 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 27,096 | 0 | 42,185 | 15.1 K to 42.2 K (+179.57 %) |
| Apr 29 2016 | EVOK | Evoke Pharma Inc | Brady Todd C | Director | Option Exercise | A | 4.81 | 19,000 | 91,390 | 19,000 | |
| Mar 18 2016 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 4.59 | 300,000 | 1,377,000 | 300,000 | |
| Jun 05 2015 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 7.85 | 90,000 | 706,500 | 90,000 | |
| Apr 24 2015 | EVOK | Evoke Pharma Inc | Brady Todd C | Director | Option Exercise | A | 6.43 | 9,000 | 57,870 | 9,000 | |
| Sep 26 2013 | EVOK | Evoke Pharma Inc | Brady Todd C | Director | Option Exercise | A | 12.00 | 18,000 | 216,000 | 18,000 |
Page: 1